Putrescine: biomarker evidence

Putrescine appears in 1 entry of the OSMF biomarker atlas, covering Long COVID. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Long COVID

Where Putrescine is reported

Also listed as: Polyamine

ConditionDirectionCompared againstAssociated symptomsSource
Long COVID↑ elevatedhealthy controlsPolyamine metabolismSaito et al. 2024

Frequently asked questions

In which conditions is Putrescine altered?

In the OSMF atlas Putrescine is reported in Long COVID. It is elevated in 1 across 1 entries.

Is there a standard clinical test for Putrescine?

The atlas entries for Putrescine do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Putrescine result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Putrescine across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/putrescine.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.